Molka Chaieb

436 total citations
17 papers, 338 citations indexed

About

Molka Chaieb is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Molka Chaieb has authored 17 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Genetics and 3 papers in Surgery. Recurrent topics in Molka Chaieb's work include Diabetes and associated disorders (3 papers), Pituitary Gland Disorders and Treatments (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Molka Chaieb is often cited by papers focused on Diabetes and associated disorders (3 papers), Pituitary Gland Disorders and Treatments (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Molka Chaieb collaborates with scholars based in Tunisia, Bahrain and France. Molka Chaieb's co-authors include Nabil Mtiraoui, Intissar Ezzidi, Wassim Y. Almawi, Touhami Mahjoub, M. Kacem, Martine Vaxillaire, Zied Aouni, Amira Turki, Aurélie Dechaume and Philippe Froguel and has published in prestigious journals such as Clinical Endocrinology, Diabetes Research and Clinical Practice and Diabetes/Metabolism Research and Reviews.

In The Last Decade

Molka Chaieb

16 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Molka Chaieb Tunisia 9 106 94 88 77 67 17 338
Rizk Elbaz Egypt 12 41 0.4× 51 0.5× 66 0.8× 67 0.9× 35 0.5× 31 320
Danxia Zheng China 7 120 1.1× 52 0.6× 75 0.9× 46 0.6× 55 0.8× 14 342
Rita Nemr Lebanon 12 130 1.2× 110 1.2× 129 1.5× 29 0.4× 38 0.6× 22 360
Houda Benrahma Morocco 12 79 0.7× 71 0.8× 114 1.3× 54 0.7× 35 0.5× 26 311
Vanesa Palau Spain 7 87 0.8× 75 0.8× 54 0.6× 9 0.1× 47 0.7× 11 367
Yoshinori Kakutani Japan 10 58 0.5× 50 0.5× 66 0.8× 19 0.2× 72 1.1× 21 297
Maki Kumada Japan 9 69 0.7× 40 0.4× 195 2.2× 13 0.2× 74 1.1× 18 407
Mary Dang United Kingdom 10 89 0.8× 121 1.3× 91 1.0× 16 0.2× 29 0.4× 25 314
Guanping Dong China 13 136 1.3× 185 2.0× 150 1.7× 13 0.2× 91 1.4× 51 471
Colin Carr United Kingdom 3 107 1.0× 107 1.1× 91 1.0× 34 0.4× 262 3.9× 5 583

Countries citing papers authored by Molka Chaieb

Since Specialization
Citations

This map shows the geographic impact of Molka Chaieb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Molka Chaieb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Molka Chaieb more than expected).

Fields of papers citing papers by Molka Chaieb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Molka Chaieb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Molka Chaieb. The network helps show where Molka Chaieb may publish in the future.

Co-authorship network of co-authors of Molka Chaieb

This figure shows the co-authorship network connecting the top 25 collaborators of Molka Chaieb. A scholar is included among the top collaborators of Molka Chaieb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Molka Chaieb. Molka Chaieb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kacem, M., et al.. (2022). Clinical, immunological, and genetic investigations in a rare association of type 1 diabetes with xeroderma pigmentosum. Pediatric Endocrinology Diabetes and Metabolism. 28(3). 233–237. 1 indexed citations
2.
Kacem, M., et al.. (2021). Association of an empty sella and grave's disease in a patient with acromegaly: a case report. Pan African Medical Journal. 38. 394–394. 2 indexed citations
3.
Kacem, M., et al.. (2021). Safety Assessment and Potential Risks of the Glucagon Stimulation Test inthe Diagnosis of Secondary Adrenal Insufficiency. Current Drug Safety. 17(1). 59–63. 3 indexed citations
4.
Kacem, M., et al.. (2021). Pituitary apoplexy of a giant prolactinoma during pregnancy. Gynecological Endocrinology. 37(9). 863–866. 8 indexed citations
5.
Chaieb, Molka, et al.. (2018). Etude sur le diabète aigu cétosique inaugural dans un hôpital du Centre-Est Tunisien. Pan African Medical Journal. 31. 134–134. 3 indexed citations
7.
Chaieb, Molka, et al.. (2018). Clinical evaluation of erectile dysfunction in diabetic patients by IIEF5 Score. Endocrine Abstracts. 1 indexed citations
8.
Sahli, Jihène, J. Maatoug, Sihem Ben Fredj, et al.. (2017). Clustering of chronic diseases risk factors among adolescents: a quasi-experimental study in Sousse, Tunisia. International Journal of Adolescent Medicine and Health. 31(4). 3 indexed citations
9.
Bouali, Nouha, Soumaya Mougou, Jérôme Bouligand, et al.. (2015). Analysis of FMR1 gene premutation and X chromosome cytogenetic abnormalities in 100 Tunisian patients presenting premature ovarian failure. Annales d Endocrinologie. 76(6). 671–678. 9 indexed citations
10.
Mtiraoui, Nabil, Intissar Ezzidi, Amira Turki, et al.. (2011). Renin–angiotensin–aldosterone system genotypes and haplotypes affect the susceptibility to nephropathy in type 2 diabetes patients. Journal of the Renin-Angiotensin-Aldosterone System. 12(4). 572–580. 21 indexed citations
11.
Ezzidi, Intissar, Amira Turki, Safia A. Messaoudi, et al.. (2010). Common polymorphisms of calpain-10 and the risk of Type 2 Diabetes in a Tunisian Arab population: a case-control study. BMC Medical Genetics. 11(1). 75–75. 30 indexed citations
12.
Ezzidi, Intissar, Nabil Mtiraoui, Stéphane Cauchi, et al.. (2009). Contribution of type 2 diabetes associated loci in the Arabic population from Tunisia: a case-control study. BMC Medical Genetics. 10(1). 33–33. 68 indexed citations
13.
Ezzidi, Intissar, Nabil Mtiraoui, M. Kacem, et al.. (2009). Identification of specific angiotensin‐converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy. Diabetes/Metabolism Research and Reviews. 25(8). 717–724. 26 indexed citations
14.
Ezzidi, Intissar, Nabil Mtiraoui, M. Kacem, et al.. (2008). Interleukin‐10–592C/A, –819C/T and –1082A/G promoter variants affect the susceptibility to nephropathy in Tunisian type 2 diabetes (T2DM) patients. Clinical Endocrinology. 70(3). 401–407. 42 indexed citations
15.
Mtiraoui, Nabil, Intissar Ezzidi, M. Kacem, et al.. (2008). Predictive value of interleukin‐10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients. Diabetes/Metabolism Research and Reviews. 25(1). 57–63. 31 indexed citations
16.
Mtiraoui, Nabil, Intissar Ezzidi, Molka Chaieb, et al.. (2006). MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Research and Clinical Practice. 75(1). 99–106. 85 indexed citations
17.
Zaouali, Monia, et al.. (2006). Circadian leptin, insulin and cortisol rhythms in obese subjects. Biological Rhythm Research. 38(1). 9–17. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026